Technology ID
TAB-2612

Real-time TaqMan RT-PCR Assays for Selective Detection of Human Rhinovirus

E-Numbers
E-177-2013-0
Lead Inventor
Lu, Xiaoyan (CDC)
Co-Inventors
Erdman, Dean (CDC)
Applications
Diagnostics
Therapeutic Areas
Infectious Disease
Development Status
  • Early-stage
  • In vitro data available
  • Lead IC
    CDC
    ICs
    CDC
    This invention relates to selective detection of human rhinovirus (HRV) in biological media. Specifically, this invention discloses a real-time TaqMan RT-PCR assay targeting the 5'-noncoding region of the HRV genome. This is a one-step, real-time nucleic acid assay that offers rapid, sensitive, and quantitative results. The assay is validated against all 100 recognized HRV prototype strains.

    HRV is the most frequent cause of the common cold. From a clinical standpoint, diagnosis of HRV infection is quite difficult as the related symptoms can be caused by other agents as well. Additionally, laboratory detection of HRV is challenging as HRV exhibits extreme antigenic variability and certain strains cannot be maintained by cell culture.
    Commercial Applications
    • Development of human rhinovirus (HRV) diagnostics
    • Acute lower respiratory illness diagnostics and investigation
    Competitive Advantages
    • Validated against all 100 human rhinovirus prototype strains
    • Rapid, sensitive and quantitative
    • One-step assay
    • Easily adapted to kit form
    Licensing Contact:
    Motley, Jonathan
    jonathan.motley@nih.gov
    Phone: 301-496-2644